T 1501/17 (Lapse of patent) of 23.06.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T150117.20200623
- Date of decision
- 23 June 2020
- Case number
- T 1501/17
- Online on
- 29 June 2020
- Petition for review of
- -
- Application number
- 08846814.5
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND ANTI-TUMOR PLATINUM COMPLEX
- Applicant name
- Eisai R&D Management Co., Ltd.
- Opponent name
- Generics (U.K.) Limited (trading as Mylan)
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 84(1) (2007)European Patent Convention R 100(1) (2007)
- Keywords
- Lapse of patent in all designated states - termination of appeal proceedings
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal proceedings are terminated.